Silver Book Fact

A study on the impact of diet on age-related macular degeneration (AMD) found that those who took the highest amounts of carotenoids, such as lutein and zeaxanthin, had a 43% lower risk of age-related macular degeneration than those who took the least amounts.

Seddon, Johanna M., Umed A. Ajani, Robert D. Sperduto, Rita Hiller, Norman Blair, Thomas C. Burton, Marilyn D. Farber, Evangelos S. Gragoudas, Julia Haller, Dayton D. Miller, et al. Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration. JAMA. 1994; 272(18): 1413-20. http://jama.ama-assn.org/cgi/content/abstract/272/18/1413

Reference

Title
Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration
Publication
JAMA
Publication Date
1994
Authors
Seddon, Johanna M., Umed A. Ajani, Robert D. Sperduto, Rita Hiller, Norman Blair, Thomas C. Burton, Marilyn D. Farber, Evangelos S. Gragoudas, Julia Haller, Dayton D. Miller, et al
Volume & Issue
Volume 272, Issue 18
Pages
1413-20
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The use of antioxidant vitamins and other new therapies for age-related macular degeneration (AMD) could reduce visual impairment and blindness from the disease by 35%.  
  • Because the resource use and direct cost of glaucoma treatment and management increases as the disease severity worsens– from an average $623 per early-stage patient to $2,511 per late-stage patient–…  
  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of over $472.1 million– in 1994 dollars.  
  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of 94,304 person-years of sight.  
  • The ACCORD Eye Study found that intensive glycemia control–compared with standard blood sugar control–in high risk type 2 diabetics, decreased progression of diabetic retinopathy by around 1/3 over 4 years–from…